Hirtle Callaghan & Co’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-550	Closed	-$34K	–	567
2014 Q2	$34K	Sell	550 -200	-27%	-$12.4K	﹤0.01%	404
2014 Q1	$51K	Hold	750	–	–	0.01%	348
2013 Q4	$53K	Buy	+750	New	+$53K	0.01%	326